Other News To Note
Tuesday, July 3, 2012
Cleveland BioLabs Inc., of Buffalo, N.Y., and its subsidiary Incuron LLC, of Moscow, said a study demonstrating that CBL0137 counteracted tumor formation in a mouse spontaneous breast cancer model was published online in Cancer Prevention Research.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.